References
- Amman K H, Griffin J D, Elias A., et al. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapyinduced myelosuppression. N Engl J Med 1988; 319: 593–598
- Bronchud M H, Scarffe J H, Thatcher N., et al. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987; 56: 809–813
- Morstyn G, Campbell L, Souza L. M., et al. Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet March 1988; 26: 667–672
- Nemunaitis J, Singer J W, Buckner C. K., et al. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 1988; 72(2)834–836
- Glaspy J A, Baldwin G C, Robertson P. A., et al. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor. Ann Intern Med 1988; 109: 789–795
- Champlin R E, Nimer S D, Ireland P., et al. Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989
- Kleinerman E S, Knowles R D, Lachman L B, Gutterman J U. Effect of recombinant granulocyte/macrophage colony-stimulating factor on human monocyte activity in vitro and following intravenous administration. Cancer Res 1988; 48: 2604–2609